Genetically engineered mouse (GEM) models of NF1 and NF2 develop nerve sheath tumors in restricted locations that differ from humans.[29]–[31] Subsequent investigations of molecular biomarkers in both GEM and human tissue may help identify biological factors involved in these unique disease manifestations. Here, NF1 is linked to nerve sheath neoplasm.